These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5427311)

  • 21. Acquired inhibitors of coagulants.
    Bidwell E
    Annu Rev Med; 1969; 20():63-74. PubMed ID: 4183761
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk of inhibitor development after intermediate purity coagulation factor concentrates: is it truly low?
    Mannucci PM
    Thromb Haemost; 1995 Sep; 74(3):997. PubMed ID: 8571341
    [No Abstract]   [Full Text] [Related]  

  • 23. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
    Kraiem I; Hadhri S; El Omri H; Sassi R; Chaabani W; Ennabli S; Skouri H
    Ann Biol Clin (Paris); 2012; 70(6):659-65. PubMed ID: 23207810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating anticoagulants.
    Zieve PD; Levin J
    Major Probl Intern Med; 1976; 10():65-70. PubMed ID: 785117
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased resistance of factor IXa-factor VIII complex against inactivation by granulocyte proteases.
    Váradi K; Elõdi S
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):571-8. PubMed ID: 6777896
    [No Abstract]   [Full Text] [Related]  

  • 26. Acquired Factor VIII inhibitor (a case report).
    Irby S; Rogers JS; Wolf DC
    W V Med J; 1983 Mar; 79(3):49-51. PubMed ID: 6405541
    [No Abstract]   [Full Text] [Related]  

  • 27. Modification of the Bethesda assay for factor VIII or IX inhibitors to improve efficiency.
    Gadarowski JJ; Czapek EE; Ontiveros JD; Pedraza JL
    Acta Haematol; 1988; 80(3):134-8. PubMed ID: 3143212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of patients with factor VIII and IX inhibitors.
    Nilsson IM; Berntorp E; Freiburghaus C
    Thromb Haemost; 1993 Jul; 70(1):56-9. PubMed ID: 8236114
    [No Abstract]   [Full Text] [Related]  

  • 29. Factor VIII and IX inhibitors after exposure to heat-treated concentrates.
    Pasi KJ; Hamon MD; Perry DJ; Hill FG
    Lancet; 1987 Mar; 1(8534):689. PubMed ID: 2882112
    [No Abstract]   [Full Text] [Related]  

  • 30. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired circulating anticoagulants.
    Kunkel LA
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1341-57. PubMed ID: 1452516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of hemorrhagic disorders.
    Nemerson Y
    Med Clin North Am; 1973 Mar; 57(2):531-41. PubMed ID: 4570937
    [No Abstract]   [Full Text] [Related]  

  • 34. Acquired factor VIII inhibitor associated with lung abscess.
    Ganly PS; Isaacs JD; Laffan MA; Haslett C; Hows JM
    Br Med J (Clin Res Ed); 1987 Oct; 295(6602):811. PubMed ID: 3119053
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunocoagulopathies as a possible cause of acquired hemorrhagic diathesis].
    Klare M; Möller T; Hanke P; Weller P; Seige K
    Z Gesamte Inn Med; 1983 May; 38(10):277-80. PubMed ID: 6412468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired factor VIII inhibitor associated with prostatic cancer: successful treatment with steroid and immunosuppressive therapy.
    Moccia F; Tognoni E; Boccaccio P
    Ann Ital Med Int; 2000; 15(2):172-6. PubMed ID: 10920509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical effects of FEIBA on hemophilia patients with inhibitors to factor VIII or IX].
    Iizuka A; Kuwashima M; Nagao T
    Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):987-92. PubMed ID: 6818811
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial: Factor VIII inhibitors.
    Deykin D
    N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
    [No Abstract]   [Full Text] [Related]  

  • 39. Continuous infusion of porcine factor VIII for the treatment of patients with factor VIII inhibitors.
    Bona RD; Riberio M; Klatsky AU; Panek S; Magnifico M; Rickles FR
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):32-5. PubMed ID: 8480196
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular deficiencies of human blood coagulation.
    Beck EA
    Experientia; 1972 Jan; 28(1):1-7. PubMed ID: 5013049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.